Europe — EMA
Olanzapine Ab
Olanzapine, the active ingredient in Olanzapine Ab, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Ab, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
GNH USA supplies Olanzapine Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine is an atypical antipsychotic that modulates dopamine and serotonin pathways in psychiatric disorders. - Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Bipolar I disorder (manic phase): Controls acute manic episodes and stabilises mood. - Schizoaffective disorder: Alleviates psychotic symptoms and mood disturbances.
What are the side effects of Olanzapine?
Olanzapine may cause a range of adverse reactions, most of which are dose‑dependent and reversible.
Common Side Effects: - Weight gain: Increased appetite and caloric intake. - Sedation: Drowsiness or feeling of being slowed. - Dry mouth: Reduced salivation. - Constipation: Decreased bowel motility. - Elevated triglycerides: Changes in lipid metabolism. - Orthostatic hypotension: Light‑headed
Serious or Rare Side Effects: - Neuroleptic malignant syndrome: Potentially life‑threatening reaction. - Tardive dyskinesia: Involuntary, repetitive movements. - Hyperglycaemia : - Seizure - Agranulocytosis - Elevated
